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ABSTRACT 
Public health policy/law is a discipline that seeks to identify opportunities and implement mechanisms to achieve justice in the 
public health sector. Several public health policies and programs have been implemented by virtue of the Affordable Care Act 
(ACA), and these policies and programs seek to decrease America’s “paradox of excess and deprivation” and address 
socioeconomic barriers that exist in the U.S. healthcare system. Private healthcare market interests have accused the ACA of 
intruding heavily into the professional autonomy of the medical profession, eroding healthcare market competition, and driving up 
national healthcare spending. Counter-arguments defending the ACA state that the law exposes the limitations to such professional 
autonomy of the medical profession, primarily because the U.S. healthcare system is currently ridden with excess, waste, and 
social injustice. This review article outlines the types of policies and laws governing healthcare, unique healthcare issues faced by 
particularly vulnerable populations, and future challenges and opportunities under the ACA. Lastly, the article provides 
recommendations to address future challenges and opportunities under the ACA, so as to balance the scales between private 
market interests and public health equity. 
 
Introduction 
Public health policy/law concentrates on understanding and formulating ways to achieve a delicate balance between the business 
autonomy of the private healthcare market and government regulation of the private healthcare market.1 A major and current 
example of a public health policy/law is the Patient Protection and Affordable Care Act (commonly referred to as the “ACA”). The 
ACA (42 U.S.C. § 18001) was signed into law by President Barack Obama and upheld by the Supreme Court in 20122.2  
Private market interests have since challenged the ACA, citing that the law intrudes heavily into the professional autonomy of the 
medical profession, erodes healthcare market competition, and drives up healthcare spending in the form of pent-up demand.1 
Counter-arguments defending the ACA state that the law exposes the limitations to such autonomy over the medical profession, 
as the U.S. healthcare system is ridden with excess, waste, and social injustice. Additional examples of these limitations are as 
follows: 1) the majority of our healthcare system is currently paid based on its volume versus its provided value; 2) the U.S. 
experiences poorer health outcomes than other developed nations despite the fact that the U.S. spends the more on its healthcare 
than any other developed nation; and 3) there is a lack of full stakeholder engagement to provide better coordinated and informed 
care to patient populations.  
Public health policy seeks to balance the scales between government and private market interests. The ACA is a timely example 
of added weight to the scale of public health governance to counter-balance the weight of the private healthcare market. Competing 
interests between these two forces date back to the beginning of the twentieth century, with the ACA’s weight resembling that of 
the Social Security Amendments of 1965, our government’s second most recent quantum leap toward equitable healthcare for 
those of low socioeconomic status. The discussion below outlines the types of policies and laws governing healthcare, unique 
healthcare issues faced by particularly vulnerable populations, and future challenges and opportunities under the ACA. Lastly, the 
article provides brief recommendations on best practices to address future challenges presented by the ACA. 
 
 
Issues and Challenges: The Development of Fair and Equitable Health Policy                2 
 
© The Internet Journal of Allied Health Sciences and Practice, 2016 
Policies and Laws Governing Healthcare 
The philosophical sub-discipline of bioethics plays a major role in healthcare legislation. Thus, there are two traditional types of 
policies and laws governing healthcare: 1) those defining the function and power of public health agencies, and 2) those directly 
serving to protect and promote public health. Together, these two types of policies and laws promulgate both the power and 
intentions of the government to preserve the health of the population.1 
The executive branch of the federal government implements and enforces laws and appoints heads of federal government 
agencies. The U.S. Department of Health and Human Services (HHS) is the cabinet-level department of the U.S. government that 
oversees and addresses human health issues and defines the function and power of its several operating divisions and agencies. 
Some HHS agencies include the Centers for Medicare and Medicaid Services (CMS) and the Substance Abuse and Mental Health 
Services Administration. The HHS is tasked with oversight of the ACA; however, the Internal Revenue Service is responsible for 
overseeing the tax provisions within the ACA.   
Governments have the ability to incentivize and promote healthy consumer behavior not only via legislation at the federal and state 
level, such as through the ACA, but also at the city level. For example, in order to address the current obesity epidemic, the city of 
Berkeley, California, implemented a Pigovian tax that is charged to distributors of certain sugar-sweetened beverages such as 
sweetened teas and soda (also called “Measure D”). This city ordinance caused for a tax levy of “one cent ($0.01) per fluid ounce 
on the privilege of distributing sugar-sweetened beverage products in the city.”3 Although unsuccessful, the American Beverage 
Association, a private market interest, spent millions of dollars publicly opposing Measure D.4 In essence, Measure D serves to 
balance its governmental scale against private market interests in order to protect the public health of the city of Berkeley, 
California.  
 
Unique Healthcare Issues of Vulnerable Populations 
Financially vulnerable populations encompass those living at or slightly above the federal poverty level, while clinically vulnerable 
populations include those with high-risk, chronic conditions (such as cancer). These two populations exist both separately and 
combined, and equally struggle to afford ever-increasing and expensive out-of-pocket expenses in the form of insurance premiums, 
co-insurance, co-payments, and deductibles. Prior to the ACA, insurance payers were allowed to deny insurance coverage to 
patients with pre-existing conditions, thereby exacerbating the socioeconomic issue of unaffordable coverage and compromised 
health in low income populations with high-risk, chronic conditions.5  
Clinically vulnerable populations also include those with mental/behavioral health issues such as substance abuse disorders. 
Substance abuse occurs in various forms; alcoholism and non-medical use of prescription medications such as opiates, sedatives, 
pain-killers, and tranquilizers fall under the category of substance abuse. Patients with mental health and substance abuse issues, 
along with other medical conditions such as cancer, encompass two-thirds of high-use, high-cost patient spending in the healthcare 
system.6 Current studies also demonstrate a positive correlation between socioeconomic status, and substance abuse and mental 
disorders.7,8,9  
The forms of laws and regulations described above seek to protect and/or improve the health of vulnerable populations, and 
balance the scales between bioethics and business. The ACA is coined as a pivotal moment in our healthcare system’s history 
that, among several of its provisions and programs, increased access to care for millions of individuals. Examples include, but are 
not limited to, expanded Medicaid coverage to individuals living at or below 138% of the poverty level, government subsidized 
commercial health coverage for qualifying individuals living above 138% but below 400% of the federal poverty level, and access 
to care for high-risk cancer patient populations that were previously denied insurance coverage for their pre-existing condition.1 
Further, the ACA requires that health insurance sold to newly eligible adults on Health Insurance Exchanges or provided under 
Medicaid include coverage for substance abuse treatment.10 Table 1 provides a general overview of the ACA’s key provisions, and 
includes brief descriptions of how those features affect individuals and families, health care providers, insurers, employers, and 
taxpayers.15  
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Table 1. Key Features of the ACA Titles I-X 
ACA TITLE Key Features 
TITLE I- Quality, affordable 
health care for all 
Americans 
- Americans without health insurance coverage are given the ability to select 
personalized health insurance coverage on public market exchanges. 
- Discrimination is prohibited, such that insurers may no longer deny health 
insurance coverage to individuals and children with pre-existing medical 
conditions.  
- Young adults under age 26 may remain on their parents’ health coverage plans. 
- States given flexible options to establish basic health programs for low-income 
individuals through State Medicaid and other health subsidy programs. 
- Tax incentives and cost-sharing reductions are provided to individuals enrolled in 
qualified health plans. 
- Employers are held responsible for informing employees of available health 
coverage options, and Large Employersa are required to provide automatic 
enrollment to their employees. 
 
TITLE II- Role of public 
programs 
- Expanded Medicaid coverage to individuals and families living at or below 138 
percent of the federal poverty level. 
- Simplified Medicaid and Children's Health Insurance Program (CHIP) enrollment 
procedures.  
- Improved quality of Medicaid services, which includes support for both pregnant 
and parenting teens and women, expanded Medicaid reimbursement, and 
rebates for prescription drugs. 
- The development and inclusion of a core, recommended set of adult health quality 
measures under the Medicaid Quality Measurement Program; measures shall be 
reported to the CMS in a standardized format and on behalf of Medicaid 
beneficiaries.  
 
TITLE III- Improving the 
quality and efficiency of 
health care 
- Medicare payments are linked to quality outcomes, versus patient volume, 
through the development and use of quality reporting and physician feedback 
programs and value-based modifiers under the physician fee schedule, and by 
virtue of national strategy to improve health care quality.  
- The development of innovative patient care models, such as the Medicare Shared 
Savings Program and payment bundling for clinical episodes.  
- Ensured beneficiary access to clinical care and services, including mental health 
and ambulatory services, and integration of quality improvement and patient 
safety training and education programs for health professionals. 
- Improved payment accuracy and payment adjustments for specified services and 
products, including home health care and biosimilar products, and payment 
protections for rural health care providers.  
TITLE IV- Prevention of 
chronic disease and 
improving public health 
- Funding commitments to programs that promote illness prevention, wellness, and 
contribute to the public health.  
- Increased and improved access to preventative health services for Medicare and 
Medicaid beneficiaries.  
TITLE V- Health care 
workforce 
- Funding for employment incentives, such as scholarships and loan repayment 
programs, to increase the number of primary care physicians, nurses, physician 
assistants, mental health providers, and dental health providers in medically 
underserved areas. 
 
Note: a “Large Employer” as defined under Section 1304 of the ACA; “in connection with a group health plan with respect to a 
calendar year and a plan year, an employer who employed an average of at least 101 employees on business days during the 
preceding calendar year and who employs at least 1 employee on the first day of the plan year.” 
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Table 1. Key Features of the ACA Titles I-X (cont.) 
ACA TITLE Key Features 
TITLE VI- Transparency 
and program integrity 
- Stronger physician disclosure requirements, such as disclosure of physician 
ownership-referrals, which foster transparency and protect American taxpayers 
from fraud, waste, and abuse. 
- Identification of high-risk providers with fraud history and estoppel of penalized 
providers seeking to transfer their services to other states. 
- Improved medical staff education programs that provide training on abuse 
prevention. 
- Recovery Audit Contractor program expansion that serves to detect fraud and 
abuse, and oversee payment exchanges.  
TITLE VII- Improving 
access to innovative 
medical therapies 
- Support for innovative, medically therapeutic programs that create monetary 
savings across health systems and communities. 
- Extended discounts for prescription drugs and biologicals administered by health 
care providers to adults and children in low income communities.    
TITLE VIII- Community 
Living Assistance Services 
and Supports Act (CLASS 
Act) 
- A national, voluntary, and self-funded insurance program (tax-payer free) that pays 
for community assistance living services for disabled individuals.  
- Benefits may be used to support diverse forms of community support services, 
such as home health care that allows disabled individuals to continue to work near 
and live in their homes.  
TITLE IX- Revenue 
provisions 
- The ACA is intended to reduce the federal deficit and reduce tax-payer burden by 
more than one hundred billion dollars by the year 2020.  
- Tax credits are intended to reduce health insurance premiums and financially 
assist individuals and families with health insurance costs. 
- Revenue offset provisions seek to oversee and monitor improper health care 
spending, such as excessive remuneration paid by certain health insurers, and 
impose excise tax on considerably expensive employer-sponsored health 
coverage. 
TITLE X- Strengthening 
quality, affordable health 
care for all Americans 
- Reauthorization of the Indian Health Care Improvement Act; provides Native 
Americans with access to health care services.  
- Modernization of the Native American health care system with the goal to improve 
health care for 1.9 million Native Americans. 
 
The ACA- Looking Ahead 
The ACA afforded health insurance coverage to individuals who were either underinsured or uninsured prior to the ACA’s 
enactment. The purpose of the ACA is to increase the value of American healthcare and improve the overall health status of 
individuals through the encouragement of population-based payments for rendered medical services, preventative and evidence-
based medicine, and coordinated care. In essence, the ACA is a governmental measure and tool that is and can be used as a 
conduit to attain and achieve health equity across income levels. Policies and programs implemented by virtue of the ACA have 
great potential to decrease America’s “paradox of excess and deprivation” and address socioeconomic stereotypes and barriers 
in healthcare.8 
The ACA however, and as many know, is neither exempt from nor without limitations and critique. U.S. healthcare spending is 
expected to increase as a result of 1) increased insurance plan enrollment through Health Insurance Exchanges and Medicaid 
expansion, 2) a larger aging population, and 3) an improved economy. This increase in healthcare utilization has and will lead to 
a “pent-up demand” for healthcare services in the marketplace, and increases in cost and payment for rendered medical 
services.1,11 Many also accuse programs implemented by virtue of the ACA of interfering with and reducing the potential to introduce 
stronger private market force and competition into the healthcare marketplace, and further accuse the ACA of merely strengthening 
the market force of larger, wealthier, and better established health systems that have resources in place to implement complicated 
value-based payment structures.12 
Summary 
Now that we have briefly explored and defined some of the types of policies and laws governing healthcare, financially and 
clinically vulnerable populations, and future challenges and opportunities under the ACA, we may now summarize upon the 
notion and need to balance the scales between bioethics and the marketplace. Inaction on current issues of excess and waste in 
our healthcare system/marketplace and income inequality results in matters of life or death for millions, especially financially 
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and/or clinically vulnerable populations that are less fortunate to achieve levels of wealth that would allow them the opportunity to 
pay for expensive, yet medically necessary, medical procedures. As the U.S. market and economy improves, and as costs of 
living rise as a result, it is important to identify and implement innovative ways to balance the scales between the two forces so 
as to eliminate waste, reduce spending long-term for medially-necessary procedures, enhance patient education and access to 
care, obtain social justice, and produce healthier patient populations. 
 
Recommendations and Key Takeaways 
Although marketplace concerns about the ACA are well warranted, it is important to understand the overarching need to reduce 
waste and enhance quality and value, especially in healthcare. Costs are and can be astronomically high relative to individual 
income, and families, employers, and communities alike are sorely impacted by poor public health outcomes that could be 
prevented according to evidence-based medicine. Economic analysis projects a decrease in healthcare spending over time, 
particularly after year 2023, as a result of measures put in place by ACA provisions, which include shifting healthcare payment 
structures from fee-for-service payments that are volume-based to population-based payments that are value-based.1 Value-
based payments, also termed alternative payment models (APMs), distribute provider payments in accordance to value provided 
to patient populations, versus the number of times the providers provide a tangible service. A significant number of APMs have 
been developed and disseminated across a wide range of health networks and authorities, clinical specialties, and health 
systems. 
 
A key and laudable feature of APMs is that they promote high quality care at relatively lower costs for health consumers, and in 
financially feasible ways for providers. The American Medical Association and Center for Healthcare Quality and Payment Reform 
jointly outline three particular characteristics of successful, physician-focused APMs in their recently released Executive Summary 
of APMs: 1) APM design must be flexible and must give providers the ability to deliver the most effective and efficient patient care 
possible; 2) APMs must provide financial and tangible resources that allow its providers to deliver the highest quality care possible, 
and distribute adequate, predictable, risk-adjusted payments that are tailored to the unique characteristics of its providers’ patient 
populations; and 3) APM design must ensure, to patients and payers, that care costs will be either controlled or reduced so as to 
not sacrifice quality for the sake of lower costs, and only hold providers accountable for care quality and costs that are exclusively 
under the providers’ control. The Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) was created and implemented 
by virtue of the ACA, and strongly encourages the use of such APMs.16,17   
 
Examples of APMs include, but are not limited to, bundled or clinical episode payments and condition-based payments for physician 
services. Bundled payments can be disease- or condition-specific, and may account for multi-specialty care delivered to unique 
sets of patients undergoing specific courses of care. Condition-based payments for physician services are valuable in that 
physicians have the flexibility to use effective and efficient treatment options, regardless of cost, if utilization of lower cost options 
compromise patient care. The Clinical Episode Payment Work Group, as part of the Health Care Payment Learning and Action 
Network (HCP LAN), published a white paper summarizing its formularies of and recommendations for condition-specific clinical 
episode payments for elective joint replacement, maternity care, and coronary artery disease.18 Additional APMs endorsed by both 
the CMS and Agency for Healthcare Research and Quality include Accountable Care Organizations (ACOs) and Patient Centered 
Medical Homes (PCMHs).19,20  
 
Given that value-based payment structures, or APMs, are a relatively new concept in U.S. healthcare, it is recommended that 
stakeholders and stakeholder organizations collaborate and exchange ideas with one another in order to identify quality measures 
and quality measurement tools and approaches. Programs such as the HCP LAN and Healthy People 2020, for example, have 
been introduced by the CMS and the Office of Disease Prevention and Health Promotion, respectively, to facilitate collaboration 
among communities and business sectors to exchange such ideas.13,14 These programs encourage shared decision making and 
stakeholder engagement that must undeniably take place in order to balance the scales between the marketplace and public health 
equity.                                                                               
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